Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Octreotide (Hospira) 100 microgram/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Adenoscan 30 mg/10 mL injection, 6 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Kefzol 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Adenocor 6 mg/2 mL injection, 6 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (Alphapharm) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Adenosine (Aspen) 6 mg/2 mL injection, 6 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (Alphapharm) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefazolin (AFT) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefazolin (Sandoz) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Doribax 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (DBL) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (DBL) 500 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefazolin (Sandoz) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Bridion 200 mg/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (Alphapharm) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Bridion 500 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cefazolin (AFT) 500 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cephazolin (Alphapharm) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Virazide 6 g powder for inhalation, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Abraxane 100 mg powder for injection, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Xylocaine 1.5% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Xylocaine 1% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Lantus (insulin glargine 100 international units / 1 mL) injection, 1 x 10 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Xylocaine 0.5% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Busulfex 60 mg/10 mL injection, 8 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Xylocaine 2% with Adrenaline 1 in 200 000 injection, 5 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
OP-1 3.3 mg implant, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Multihance 7.935 g/15 mL injection, 10 x 15 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Multihance 10.58 g/20 mL injection, 10 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Multihance 2.645 g/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Dynastat 40 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Multihance 5.29 g/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ketalar 200 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Kabi) 50 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (DBL) 500 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ketamine (DBL) 200 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (DBL) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Kabi) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (DBL) 1 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Disodium Edetate (Phebra) 30 mg/mL injection, 10 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (DBL) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Ebewe) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (Pfizer (Perth)) (cytarabine 100 mg / 5 mL) injection, 1 x 5 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Thiosulfate (DBL) 25% (12.5 g/50 mL) injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Alphapharm) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Navelbine 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (DBL) 100 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Sodium Thiosulfate (DBL) 25% (2.5 g/10 mL) injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Aspen) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Link Medical Products) (vinorelbine 50 mg / 5 mL) injection, 1 x 5 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (DBL) 2 g/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (DBL) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Pierre Fabre Medicament) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (DBL) 100 mg/mL injection, 5 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Aspen) 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (Pfizer (Perth)) 500 mg/25 mL injection, 25 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (SXP) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Pierre Fabre Medicament) 50 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Keppra 500 mg/5 mL injection: concentrated, 5 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Cytarabine (Pfizer (Perth)) 1 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fortum 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Mayne Pharma) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (Pfizer (Perth)) (cytarabine 2 g / 20 mL) injection, 1 x 20 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Navelbine 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Levetiracetam (Sandoz) 500 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cytarabine (Pfizer (Perth)) 100 mg/5 mL injection, 5 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cerezyme 400 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fortum 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Cerezyme 200 units powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (SXP) 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Mayne Pharma) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (AS) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Pierre Fabre Medicament) 10 mg/mL injection, 10 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Alphapharm) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Kabi) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 2 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Kabi) 10 mg/mL injection, 10 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (DBL) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Metronidazole (Pfizer (Perth)) 0.5% (500 mg/100 mL) injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fortum 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Pierre Fabre Medicament) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Fortum 2 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (AS) 50 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Ceftazidime (Sandoz) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Ebewe) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (DBL) (vinorelbine 10 mg / 1 mL) injection, 1 x 1 mL vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Diclocil 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Vinorelbine (Link Medical Products) 10 mg/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Metronidazole (Sandoz) 0.5% (500 mg/100 mL) injection, 5 x 100 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Diclocil 500 mg powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Metronidazole (Sandoz) 0.5% (500 mg/100 mL) injection, 10 x 100 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Metronidazole (Sandoz) 0.5% (500 mg/100 mL) injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Miostat 0.01% (150 microgram/1.5 mL) intraocular injection, 1.5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Pentamidine Isethionate (DBL) 300 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Perjeta 420 mg/14 mL injection solution, 14 mL vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
Miostat 0.01% (150 microgram/1.5 mL) intraocular injection, 12 x 1.5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
Lincocin 600 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|